Key result
Resting heart rate fails to predict DKD progression, MACE, or mortality in T2DM patients.
Why the study?
Does resting heart rate predict cardiovascular and renal outcomes in patients with type 2 diabetes?
Cohort (n=421)
Does resting heart rate predict cardiovascular and renal outcomes in patients with type 2 diabetes?
Resting heart rate does not appear to be a reliable predictor of adverse cardiovascular or renal outcomes in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Resting heart rate should not guide risk stratification in T2DM; leaves open whether alternative thresholds or measures predict outcomes in future cohorts.
Bartáková et al. (2015) conducted a cohort in Type 2 diabetes mellitus (n=421). Resting heart rate vs. Different resting heart rate cut-offs (65 and 75 bpm) was evaluated on Progression of diabetic kidney disease, major advanced cardiovascular event, and all-cause mortality. Resting heart rate (using cut-offs of 65 and 75 bpm) did not significantly predict the progression of diabetic kidney disease, major cardiovascular events, or all-cause mortality in T2DM patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: